LSP-249 |
| رقم الكتالوجGC62700 |
LSP-249 (المثال 35) ، المستخرج من براءة الاختراع WO2016011209A1 ، هو مثبط البلازما كاليكرين تحت الدراسة للوذمة الوعائية ، مع EC50 أقل من 100 نانومتر في الخلية
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1801253-04-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1].
[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.
Average Rating: 5 (Based on Reviews and 14 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *